• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEURAVI LTD. EMBOTRAP II 5X33 REVASC. DEV.; CATHETER, THROMBUS RETRIEVER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEURAVI LTD. EMBOTRAP II 5X33 REVASC. DEV.; CATHETER, THROMBUS RETRIEVER Back to Search Results
Model Number ET009533
Device Problems Difficult to Remove (1528); Activation Problem (4042)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
As reported by the field, during a mechanical thrombectomy, it was sometimes difficult to match the recommended expansion position of an embotrap ii 5x33 revascularization device (et009533, lot unknown) with the proximal end of the thrombus and the proximal gold marker.In addition, sometimes strong resistance may be felt when the device is retracted to m2 distal and m3 where the device was deployed.Inner-channels may be involved, which may be caused by tight adhesion of the inner channels to the blood vessel wall in small blood vessels.It is necessary to adjust the position of deployment, partial deployment, and re-sheath.A continuous flush was done.
 
Manufacturer Narrative
Product complaint # (b)(4).Information regarding patient weight, height, medical history, race, and ethnicity was not reported.Date of event: the date of the event was not reported.The lot number was not reported.Initial reporter: the customer contact information, including name, occupation, phone, fax, and e-mail address, was not reported.A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Manufacturer Narrative
Product complaint # (b)(4).Section b5: additional information received indicated that the device lot number is not available.No additional intervention was required due to the alleged product malfunction.There was no report of any damage to the concomitant devices.Section e1 - initial reporter phone: (b)(6).A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.Complaint conclusion: as reported by the field, during a mechanical thrombectomy, it was sometimes difficult to match the recommended expansion position of an embotrap ii 5x33 revascularization device (et009533, lot unknown) with the proximal end of the thrombus and the proximal gold marker.In addition, sometimes strong resistance may be felt when the device is retracted to m2 distal and m3 where the device was deployed.Inner-channels may be involved, which may be caused by tight adhesion of the inner channels to the blood vessel wall in small blood vessels.It is necessary to adjust the position of deployment, partial deployment, and re-sheath.A continuous flush was done.Additional information received indicated that the device lot number is not available.No additional intervention was required due to the alleged product malfunction.There was no report of any damage to the concomitant devices.The device has not been returned for analysis and therefore no further investigation can be performed at this time.The lot number is not known; therefore, a device history record review cannot be completed.Withdrawal difficulty from vessel and deployment difficulties are potential complications associated with the use of the embotrap ii revascularization device in endovascular mechanical thrombectomy.The embotrap instructions for use (ifu) warns the user to never withdraw the device against significant resistance.Assess the cause of resistance using fluoroscopy and if necessary, advance the microcatheter over the device to resheath or partially resheath to aid withdrawal.With the amount of information available and without the device for analysis, it is not possible to draw a conclusion between the device and the reported events.However, there are clinical, procedural factors, including vessel characteristics, severe tortuosity, clot burden/characteristics, device interaction, device selection, and operator technique that may have contributed to the events.As part of the post market surveillance program, information from this complaint is trended to identify statistical signals for consideration of further correction action.Since there was no evidence to suggest the events were related to a manufacturing or design issue, no corrective actions will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMBOTRAP II 5X33 REVASC. DEV.
Type of Device
CATHETER, THROMBUS RETRIEVER
Manufacturer (Section D)
NEURAVI LTD.
block 3 ballybritt business pa
galway H91 K 5YD
EI  H91 K5YD
Manufacturer (Section G)
ADVANT MEDICAL
parkmore business park west
galway H91 P V0V
EI   H91 PV0V
Manufacturer Contact
gabriel alfageme
31 technology dr
irvine, CA 92618
9497898687
MDR Report Key12655920
MDR Text Key284009895
Report Number3011370111-2021-00126
Device Sequence Number1
Product Code NRY
UDI-Device Identifier10886704081326
UDI-Public10886704081326
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K173452
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberET009533
Device Catalogue NumberET009533
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/29/2021
Initial Date FDA Received10/19/2021
Supplement Dates Manufacturer Received11/04/2021
Supplement Dates FDA Received11/09/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-